Cargando…
Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies
ATP6AP2 codes for the (pro)renin receptor and is an essential component of vacuolar H+ ATPase. Activating (pro)renin for conversion of Angiotensinogen to Angiotensin makes ATP6AP2 attractive for drug intervention. Tissue-specific ATP6AP2 inactivation in mouse suggested a strong impact on various org...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575319/ https://www.ncbi.nlm.nih.gov/pubmed/28851918 http://dx.doi.org/10.1038/s41598-017-08845-7 |
_version_ | 1783260018079956992 |
---|---|
author | Wendling, Olivia Champy, Marie-France Jaubert, Solène Pavlovic, Guillaume Dubos, Aline Lindner, Loic Jacobs, Hugues Mark, Manuel Combe, Roy Da Cruz, Isabelle Goncalves Luche, Hervé Mudgett, John S. Rosahl, Thomas Sorg, Tania Malissen, Marie Reilly, Patrick T. Hérault, Yann |
author_facet | Wendling, Olivia Champy, Marie-France Jaubert, Solène Pavlovic, Guillaume Dubos, Aline Lindner, Loic Jacobs, Hugues Mark, Manuel Combe, Roy Da Cruz, Isabelle Goncalves Luche, Hervé Mudgett, John S. Rosahl, Thomas Sorg, Tania Malissen, Marie Reilly, Patrick T. Hérault, Yann |
author_sort | Wendling, Olivia |
collection | PubMed |
description | ATP6AP2 codes for the (pro)renin receptor and is an essential component of vacuolar H+ ATPase. Activating (pro)renin for conversion of Angiotensinogen to Angiotensin makes ATP6AP2 attractive for drug intervention. Tissue-specific ATP6AP2 inactivation in mouse suggested a strong impact on various organs. Consistent with this, we found that embryonic ablation of Atp6ap2 resulted in both male hemizygous lethality and female haploinsufficiency. Next, we examined the phenotype of an induced inactivation in the adult animal, most akin to detect potential effect of functional interference of ATP6AP2 through drug therapy. Induced ablation of Atp6ap2, even without equal efficiency in all tissues (aorta, brain and kidney), resulted in rapid lethality marked by weight loss, changes in nutritional as well as blood parameters, leukocyte depletion, and bone marrow hypoplasia. Upon Atp6ap2 ablation, the colon demonstrated a rapid disruption of crypt morphology, aberrant proliferation, cell-death activation, as well as generation of microadenomas. Consequently, disruption of ATP6AP2 is extremely poorly tolerated in the adult, and severely affects various organ systems demonstrating that ATP6AP2 is an essential gene implicated in basic cellular mechanisms and necessary for multiple organ function. Accordingly, any potential drug targeting of this gene product must be strictly assessed for safety. |
format | Online Article Text |
id | pubmed-5575319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55753192017-09-01 Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies Wendling, Olivia Champy, Marie-France Jaubert, Solène Pavlovic, Guillaume Dubos, Aline Lindner, Loic Jacobs, Hugues Mark, Manuel Combe, Roy Da Cruz, Isabelle Goncalves Luche, Hervé Mudgett, John S. Rosahl, Thomas Sorg, Tania Malissen, Marie Reilly, Patrick T. Hérault, Yann Sci Rep Article ATP6AP2 codes for the (pro)renin receptor and is an essential component of vacuolar H+ ATPase. Activating (pro)renin for conversion of Angiotensinogen to Angiotensin makes ATP6AP2 attractive for drug intervention. Tissue-specific ATP6AP2 inactivation in mouse suggested a strong impact on various organs. Consistent with this, we found that embryonic ablation of Atp6ap2 resulted in both male hemizygous lethality and female haploinsufficiency. Next, we examined the phenotype of an induced inactivation in the adult animal, most akin to detect potential effect of functional interference of ATP6AP2 through drug therapy. Induced ablation of Atp6ap2, even without equal efficiency in all tissues (aorta, brain and kidney), resulted in rapid lethality marked by weight loss, changes in nutritional as well as blood parameters, leukocyte depletion, and bone marrow hypoplasia. Upon Atp6ap2 ablation, the colon demonstrated a rapid disruption of crypt morphology, aberrant proliferation, cell-death activation, as well as generation of microadenomas. Consequently, disruption of ATP6AP2 is extremely poorly tolerated in the adult, and severely affects various organ systems demonstrating that ATP6AP2 is an essential gene implicated in basic cellular mechanisms and necessary for multiple organ function. Accordingly, any potential drug targeting of this gene product must be strictly assessed for safety. Nature Publishing Group UK 2017-08-29 /pmc/articles/PMC5575319/ /pubmed/28851918 http://dx.doi.org/10.1038/s41598-017-08845-7 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Wendling, Olivia Champy, Marie-France Jaubert, Solène Pavlovic, Guillaume Dubos, Aline Lindner, Loic Jacobs, Hugues Mark, Manuel Combe, Roy Da Cruz, Isabelle Goncalves Luche, Hervé Mudgett, John S. Rosahl, Thomas Sorg, Tania Malissen, Marie Reilly, Patrick T. Hérault, Yann Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title | Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title_full | Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title_fullStr | Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title_full_unstemmed | Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title_short | Atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
title_sort | atp6ap2 ablation in adult mice impairs viability through multiple organ deficiencies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575319/ https://www.ncbi.nlm.nih.gov/pubmed/28851918 http://dx.doi.org/10.1038/s41598-017-08845-7 |
work_keys_str_mv | AT wendlingolivia atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT champymariefrance atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT jaubertsolene atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT pavlovicguillaume atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT dubosaline atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT lindnerloic atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT jacobshugues atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT markmanuel atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT comberoy atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT dacruzisabellegoncalves atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT lucheherve atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT mudgettjohns atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT rosahlthomas atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT sorgtania atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT malissenmarie atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT reillypatrickt atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies AT heraultyann atp6ap2ablationinadultmiceimpairsviabilitythroughmultipleorgandeficiencies |